Skip to main
MTCR
MTCR logo

Metacrine (MTCR) Earnings Dates & Reports

Metacrine (MTCR) Most Recent Earnings

Report DateNov 14, 2022
Period EndingQ3 2022
Est. EPS-$0.10
Actual EPS-$0.13
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Metacrine (MTCR) Earnings per Share (EPS) History

Signup for full access
Browse free

Metacrine (MTCR) Latest Earnings

The value each MTCR share was expected to gain vs. the value each share gained.

Metacrine (MTCR) reported its most recent earnings on Nov 14, 2022 for Q3 2022, posting earnings per share (EPS) of -$0.13. This exceeded analysts' expectations of -$0.10 by 30.00%, marking a Miss.

For comparison, Metacrine reported EPS of -$0.69 in the same quarter last year.

The company is expected to announce its next earnings report on 11/14/2022, with analysts projecting an EPS of $0.

Metacrine (MTCR) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2022Nov 14, 2022
-$0.10-$0.13+30.00%
DeckReportListen
Q2 2022Aug 9, 2022
-$0.25-$0.15-40.00%
Q1 2022May 12, 2022
-$0.39-$0.31-20.51%
Q4 2021Mar 30, 2022
-$0.63-$0.44-30.16%
Q3 2021Nov 11, 2021
-$0.65-$0.69+6.15%
View all

Metacrine (MTCR) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Metacrine’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 9, 2022
May 12, 2022
Mar 30, 2022
Nov 11, 2021

Metacrine (MTCR) Earnings FAQs

Metacrine (MTCR) last reported earnings on Nov 14, 2022 for Q3 2022, posting an EPS of -$0.13, which Miss the estimate of -$0.10 by 30.00%.

For Q3 2022, Metacrine (MTCR) reported an EPS of -$0.13, missing analysts' estimate of -$0.10 by 30.00%.

For Q3 2022, Metacrine (MTCR) Miss expectations with an actual EPS of -$0.13 vs. an estimated EPS of -$0.10.

Following the last earnings report on Nov 14, 2022, Metacrine (MTCR)'s stock price moved — from — to —.

The next Metacrine (MTCR) earnings call is scheduled for Nov. 14, 2022, where executives will discuss financial results and outlook.

Metacrine (MTCR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.